News

As weight-loss injections like Mounjaro and Wegovy soar in popularity across the UK, jewellers say they’re seeing an ...
The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...
With Indias rising burden of diabetes and obesity, GLP-1 drugs may play a growing role in treatment. But the excitement must ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
In this Newshour Special Edition, Navika Kumar speaks to India’s top endocrinologist Dr Ambrish Mithal on the country’s ...
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term habits still matter most.
In a paper released in Addiction, scientists reported that people with a history of alcohol use disorder who were prescribed these medications were 50% less likely to binge drink. The results were ...
A nurse has revealed a potentially life-threatening mistake GPs could be making when prescribing revolutionary weight loss ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...